Business
Secondary Listing on Frankfurt Exchange
MedPal AI PLC has announced its secondary listing on the Open Market of the Frankfurt Stock Exchange under the ticker Z1N, alongside its primary listing on AIM. This strategic move aims to broaden the company's shareholder base and increase trading liquidity by accessing Germany's large and dynamic private investor market, which saw a record 14.1 million retail investors in 2025. The listing coincides with the launch of a German-language version of MedPal AI's wellness application and plans for further expansion into the German digital health market, which is projected to grow at over 20% annually through 2030. The company will also present at an investor event in Germany in March 2026. Disclaimer*
About this update from Medpal Ai Plc
[{"type":"text","content":"\n\nMedPal AI plc\n(\"MedPal AI\" or the \"Company\")\n\nSecondary Listing on the Frankfurt Stock Exchange\nMedPal AI (AIM: MPAL, FRA: Z1N), a UK-based digital health and artificial intelligence (\"AI\") company focused on health and wellness management, is pleased to announce that the Company's ordinary shares have been admitted to trading on the Open Market (Freiverkehr) of the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse, \"FRA\"), operated by Deutsche Börse AG, with trading under the ticker Z1N commencing today.\nListing Details\n\n\n\n\nExchange\n\n\nFrankfurt Stock Exchange (Frankfurter Wertpapierbörse)\n\n\n\n\nMarket Segment\n\n\nOpen Market (Freiverkehr)\n\n\n\n\nTrading Symbol\n\n\nZ1N\n\n\n\n\nISIN\n\n\nGB00BTRC7N37\n\n\n\n\nWKN (German Securities ID)\n\n\nA41GSJ\n\n\n\n\n \nThe Frankfurt listing is a secondary listing and sits alongside the Company's primary quotation on the AIM market of the London Stock Exchange. Trading in the Company's shares on the AIM market will continue as previously and the Company will continue to make all regulatory disclosures via RNS.\nStrategic Rationale\nGermany represents one of Europe's largest and most dynamic private investor markets. According to figures published by Deutsches Aktieninstitut, the number of retail investors in Germany reached a new record high of 14.1 million in 2025, driven in particular by younger investors up to the age of 39 who now represent the largest investor cohort.\nThis growing pool of engaged private investors, combined with the Frankfurt Stock Exchange's position as the third largest exchange in Europe by market capitalisation and its role as a trading venue primarily serving private investors with access to over one million securities, provides the Company with a significant opportunity to broaden its shareholder base and increase trading liquidity.\nThe rise of low-cost European neo-broker platforms has further democratised access to dual-listed securities on the German exchanges, enabling retail investors to trade at minimal cost. The Board believes that a dual listing in Frankfurt positions MedPal AI to capitalise on these favourable structural trends and to build visibility among a new and substantial audience of European retail investors.\nThe Frankfurt listing also coincides with the Company's planned expansion into the German mark...